SynthesisJAMA2018

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

Sean L Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.